Evaluation of Vascular Health Profile in Predicting Venous Thromboembolism

Evaluation of Vascular Health Profile in Predicting Venous Thromboembolism
Recruiting
1 years - 99 years
All
100 participants needed

Brief description of study

The main goal of this study is to utilize previously validated cytometric markers of to identify cancer patients at high risk of VTE. The primary outcome will be DVT or pulmonary embolism (PE). Patients with pancreatic and brain cancer will be enrolled as these patients are known to have higher rates of VTE relative to other forms of cancer. Patients will receive a screening duplex ultrasound, interval 3 month ultrasound for asymptomatic DVT and will be followed longitudinally for one year. Blood will be collected during the initial screening, at the three month interval follow-up (at time of second ultrasound) and any VTE event over the course of the year for cytometric analysis and MP TF activity.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pancreatic Neoplasms
  • Age: 1 years - 99 years
  • Gender: All
Updated on 19 Feb 2024. Study ID: 820651

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.